Grantham Mayo Van Otterloo & Co. LLC Sells 433,844 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Grantham Mayo Van Otterloo & Co. LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.0% during the 4th quarter, HoldingsChannel reports. The fund owned 1,063,470 shares of the medical equipment provider’s stock after selling 433,844 shares during the period. Intuitive Surgical accounts for approximately 1.8% of Grantham Mayo Van Otterloo & Co. LLC’s portfolio, making the stock its 21st biggest holding. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Intuitive Surgical were worth $555,089,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $28,000. Summit Securities Group LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical in the fourth quarter worth about $31,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 8.7 %

ISRG stock opened at $451.58 on Friday. The business’s 50-day moving average price is $545.18 and its 200-day moving average price is $532.30. The stock has a market cap of $160.84 billion, a P/E ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Bernstein Bank increased their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Truist Financial reduced their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.